Search Results

Sunitinib Malate 500mg 500mg  | Purity Not Available

Adooq Bioscience

Sunitinib is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST).

More Information Supplier Page

Sunitinib Malate 50mg 50mg  | Purity Not Available

Adooq Bioscience

Sunitinib is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST).

More Information Supplier Page

Sunitinib Malate 200mg 200mg  | Purity Not Available

Adooq Bioscience

Sunitinib is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST).

More Information Supplier Page

Sunitinib Malate 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

Sunitinib is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST).

More Information Supplier Page

Sunitinib Malate 100mg 100mg  | Purity Not Available

Adooq Bioscience

Sunitinib is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST).

More Information Supplier Page

Staurosporine 10mg 10mg  | Purity Not Available

Adooq Bioscience

Staurosporine is a natural product originally isolated in 1977 from the bacterium Streptomyces staurosporeus. The main biological activity of staurosporine is the inhibition of protein kinases through the prevention of ATP binding to the kinase. This is achieved through the stronger affinity of staurosporine to the ATP-binding site on the kinase.

More Information Supplier Page

SRT1720 50mg 50mg  | Purity Not Available

Adooq Bioscience

SRT1720 is an inhibitor developed intended as a small-molecule activator of the sirtuin subtype SIRT1.

More Information Supplier Page

SRT1720 5mg 5mg  | Purity Not Available

Adooq Bioscience

SRT1720 is an inhibitor developed intended as a small-molecule activator of the sirtuin subtype SIRT1.

More Information Supplier Page